FR10C0040I1 - IMMUNOGENIC COMPOSITION OF LH-RH AND METHODS CONCERNING THE SAME - Google Patents

IMMUNOGENIC COMPOSITION OF LH-RH AND METHODS CONCERNING THE SAME

Info

Publication number
FR10C0040I1
FR10C0040I1 FR10C0040C FR10C0040C FR10C0040I1 FR 10C0040 I1 FR10C0040 I1 FR 10C0040I1 FR 10C0040 C FR10C0040 C FR 10C0040C FR 10C0040 C FR10C0040 C FR 10C0040C FR 10C0040 I1 FR10C0040 I1 FR 10C0040I1
Authority
FR
France
Prior art keywords
same
immunogenic composition
methods concerning
concerning
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR10C0040C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR10C0040I1 publication Critical patent/FR10C0040I1/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention relates to the use of immunogenic LHRH compositions for the achievement of the production gains in male pigs of decreasing feed conversion ratios while controlling boar taint by immunocastration.
FR10C0040C 1997-07-09 2010-08-24 IMMUNOGENIC COMPOSITION OF LH-RH AND METHODS CONCERNING THE SAME Active FR10C0040I1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO7768A AUPO776897A0 (en) 1997-07-09 1997-07-09 A method of achieving production gains in livestock and agents useful for same
PCT/AU1998/000532 WO1999002180A1 (en) 1997-07-09 1998-07-09 Immunogenic lhrh compositions and methods relating thereto

Publications (1)

Publication Number Publication Date
FR10C0040I1 true FR10C0040I1 (en) 2010-10-15

Family

ID=3802056

Family Applications (2)

Application Number Title Priority Date Filing Date
FR10C0035C Active FR10C0035I2 (en) 1997-07-09 2010-07-09 IMMUNOGENIC COMPOSITION OF LH-RH AND METHODS CONCERNING THE SAME
FR10C0040C Active FR10C0040I1 (en) 1997-07-09 2010-08-24 IMMUNOGENIC COMPOSITION OF LH-RH AND METHODS CONCERNING THE SAME

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR10C0035C Active FR10C0035I2 (en) 1997-07-09 2010-07-09 IMMUNOGENIC COMPOSITION OF LH-RH AND METHODS CONCERNING THE SAME

Country Status (19)

Country Link
US (6) US7534441B2 (en)
EP (4) EP2191839A3 (en)
JP (3) JP5116916B2 (en)
KR (2) KR100680631B1 (en)
AT (1) ATE458493T1 (en)
AU (2) AUPO776897A0 (en)
CA (1) CA2294865C (en)
CY (2) CY1109968T1 (en)
DE (2) DE69841521D1 (en)
DK (1) DK1007084T3 (en)
ES (1) ES2339308T3 (en)
FR (2) FR10C0035I2 (en)
LU (1) LU91711I2 (en)
NZ (1) NZ502080A (en)
PL (1) PL200495B1 (en)
PT (1) PT1007084E (en)
TW (1) TWI235666B (en)
WO (1) WO1999002180A1 (en)
ZA (1) ZA986074B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO776897A0 (en) 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
ES2233284T3 (en) 1999-02-17 2005-06-16 Pfizer Products Inc. FUSION PROTEINS THAT UNDERSTAND CARRIERS THAT MAY INDUIT A DUAL IMMUNE RESPONSE.
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
WO2006027300A2 (en) * 2004-08-04 2006-03-16 Cytos Biotechnology Ag Carrier conjugates of gnrh-peptides
WO2006129162A2 (en) * 2005-06-01 2006-12-07 Pfizer Products Inc. Vaccine compositions and methods for the treatment of urinary incontinence
WO2008110912A1 (en) * 2007-03-14 2008-09-18 Pfizer Inc. Fertility regulation in horses
CN104854093B (en) 2012-12-03 2016-10-12 辉瑞大药厂 New SARM
KR101918381B1 (en) * 2017-01-11 2018-11-13 이경민 Manufacturing method of cloisonne crafts and cloisonne crafts manufactured thereby
KR102477054B1 (en) * 2020-03-24 2022-12-14 주식회사 바이오앱 Recombinant Protein for Removing Boar Taint and Vaccine Composition Comprising the Same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
DE3411224A1 (en) * 1984-03-27 1985-10-10 Hoechst Ag, 6230 Frankfurt METHOD FOR THE RACEMATAR PRODUCTION OF INTERMEDIATE PEPTIDE PRODUCTS OF THE GONADORELIN AND GONADORELINANALOGA SYNTHESIS AND NEW INTERMEDIATE PRODUCTS IN THIS METHOD
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
NZ221306A (en) * 1986-08-15 1990-02-26 Commw Scient Ind Res Org 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
WO1988005308A1 (en) * 1987-01-14 1988-07-28 Commonwealth Scientific And Industrial Research Or Anti reproductive hormone
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
WO1990009799A1 (en) * 1989-02-23 1990-09-07 Colorado State University Research Foundation GnRH ANALOGS FOR DESTROYING GONADOTROPHS
NL8900726A (en) 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund PEPTIDE, IMMUNOGENIC COMPOSITION AND VACCINE OR MEDICINAL PRODUCT; METHOD FOR IMMUNIZING A MAMMAL AGAINST LHRH, AND METHOD FOR IMPROVING THE MEAT QUALITY OF PIGS
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
EP0446313B1 (en) * 1989-08-25 1996-07-31 Biotechnology Australia Pty. Ltd. Fusion proteins comprising TraTp and at least one LHRH analogue
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
PT501882E (en) * 1991-03-01 2000-12-29 Merial Sas ANTI-LHRM IMMUNEUTRALIZATION PROCESS OF NON-CASTRATED MALE ANIMALS AND PEPTIDE FOR THAT END
ATE191147T1 (en) * 1991-07-26 2000-04-15 Commw Scient Ind Res Org SYSTEM FOR PROVIDING A PEPTIDE-BASED VACCINE THAT FORMES ITS OWN ADJUVANT AND ITS PRODUCTION
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
US5614487A (en) * 1993-05-28 1997-03-25 Genentech, Inc. Sustained release pharmaceutical composition
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
USRE39048E1 (en) * 1995-06-07 2006-03-28 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
DK0832107T3 (en) 1995-06-07 2001-11-19 Dlo Inst Voor Dierhouderij En Enhanced peptide, immunogenic composition and vaccine or medical preparation, method of immunizing animals against the hormone LHRH as well as analogues of the LHRH tandem peptide repeat peptide and their use as a vaccine
WO1997015316A1 (en) 1995-10-27 1997-05-01 Merck & Co., Inc. Conjugates of gonadotropin releasing hormone
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6013770A (en) * 1997-07-21 2000-01-11 Washington State University Chimeric contraceptive vaccines

Also Published As

Publication number Publication date
US20110293647A1 (en) 2011-12-01
AUPO776897A0 (en) 1997-07-31
EP2196213A1 (en) 2010-06-16
JP2010059167A (en) 2010-03-18
ZA986074B (en) 1999-03-16
KR20010021623A (en) 2001-03-15
DE69841521D1 (en) 2010-04-08
AU8200198A (en) 1999-02-08
DK1007084T3 (en) 2010-05-03
EP1007084A4 (en) 2003-07-02
US7534441B2 (en) 2009-05-19
US20090291098A1 (en) 2009-11-26
US20140271695A1 (en) 2014-09-18
JP5116916B2 (en) 2013-01-09
WO1999002180A1 (en) 1999-01-21
TWI235666B (en) 2005-07-11
US20060024290A1 (en) 2006-02-02
CY2010013I2 (en) 2012-01-25
EP2191839A3 (en) 2010-09-08
EP1007084A1 (en) 2000-06-14
KR100680631B1 (en) 2007-02-09
CY2010013I1 (en) 2012-01-25
EP1007084B1 (en) 2010-02-24
FR10C0035I1 (en) 2010-08-27
ES2339308T3 (en) 2010-05-18
AU725562B2 (en) 2000-10-12
LU91711I2 (en) 2010-09-28
DE122010000033I1 (en) 2011-12-01
EP2316477A1 (en) 2011-05-04
CA2294865A1 (en) 1999-01-21
KR20060101554A (en) 2006-09-25
NZ502080A (en) 2001-09-28
JP2001509489A (en) 2001-07-24
CY1109968T1 (en) 2012-01-25
ATE458493T1 (en) 2010-03-15
JP5231378B2 (en) 2013-07-10
PT1007084E (en) 2010-04-08
JP2013006862A (en) 2013-01-10
CA2294865C (en) 2013-05-21
PL200495B1 (en) 2009-01-30
US20120328639A1 (en) 2012-12-27
PL338037A1 (en) 2000-09-25
US20090226484A1 (en) 2009-09-10
EP2191839A2 (en) 2010-06-02
US8741303B2 (en) 2014-06-03
FR10C0035I2 (en) 2012-06-22

Similar Documents

Publication Publication Date Title
FR10C0035I2 (en) IMMUNOGENIC COMPOSITION OF LH-RH AND METHODS CONCERNING THE SAME
ATE200619T1 (en) MICROBIAL OILS AND THEIR USES
IL149459A0 (en) Recombinant gelatins
EP1401259A4 (en) Delta-4 desaturase genes and uses thereof
EP0431302A3 (en) Use of curable cycloaliphatic derivatives in putty compositions
AU5090401A (en) Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
TR200200068T2 (en) Mathematical trifluorobutens
HK1044349A1 (en) Compositions comprising 1,1,1,3,3-pentafluorobutane and use of said compositions.
HUT40331A (en) Process for preparing pharmaceutical compositions containing a combination of dihidro-pyridines and ace-inhibitors
UA29473C2 (en) Fungicidal composition, method to control phytopathogenic fungi
GB9807114D0 (en) Novel process
TW277050B (en)
ATE494375T1 (en) FRAZZLED NUCLEOTIDE SEQUENCES, EXPRESSION PRODUCTS, COMPOSITIONS AND USES
MD780F1 (en) Composition of vodka
MD557G2 (en) Balsam ingredients composition
RS49786B (en) Procedure of foliar feeding for obtaining plants with desired content and distribution of selenium
AU6601000A (en) 3-oxopropane-1-sulphonic acids and sulphonates
IL156966A0 (en) Compositions comprising cyclohexamantane
BG103572U (en) Means for fertilizing the soil and neutralizing the soil acidity